this post was submitted on 10 May 2024
395 points (92.5% liked)
Technology
59719 readers
2645 users here now
This is a most excellent place for technology news and articles.
Our Rules
- Follow the lemmy.world rules.
- Only tech related content.
- Be excellent to each another!
- Mod approved content bots can post up to 10 articles per day.
- Threads asking for personal tech support may be deleted.
- Politics threads may be removed.
- No memes allowed as posts, OK to post as comments.
- Only approved bots from the list below, to ask if your bot can be added please contact us.
- Check for duplicates before posting, duplicates may be removed
Approved Bots
founded 2 years ago
MODERATORS
you are viewing a single comment's thread
view the rest of the comments
view the rest of the comments
Of course it is. The what neuralink is touting is the exact same situation that company was in. What happened there was they were creating an application for types of rare retinal blindness with the hopes that some other research would magically come along that makes it apply to other types of blindness and give them a market they could properly scale in. Surprise Surprise, no such deus ex machina occurred and the company could not see a path to profitability.
Neuralink is the exact same, cervical vertebra paralysis has less invasive adaptive mechanisms that are cheaper to implement, so there's no way this will ever be a profitable approach with that alone. They're hoping that this will magic into some brain machine interface without any actual hope that is going to happen.
The basic research just isn't there to be doing this shit, but the investor dollars need to be put somewhere.